Updates in management of gastro-oesophageal cancer related pain

• Autorzy: Elzohry A.A.M. , Fikry N.M. , Elhamed M.F.A. , Mohammed K.F.
• Języki publikacji: EN

Abstrakty

EN

Gastro-esophageal cancer is one of the most common malignant tumours of the digestive tract. Pain is common in these cancer patients, particularly in the advanced stage of disease when the prevalence is estimated to be more than 70% contributing to poor physical and emotional well-being. The objective of this review is to illustrate the incidence of Gastro-esophageal cancer and demonstrate different methods to control pain related to Gastro-esophageal

• Wydawca: -
• Czasopismo: World News of Natural Sciences
• Rocznik: 2019
• Tom: 23
• Opis fizyczny: p.94-103,fig.,ref.

Twórcy

autor

Elzohry A.A.M.

• ICU and pain Relief, South Egypt Cancer Institute, Assiut University, Assiut, Egypt

autor

Fikry N.M.

• South Egypt Cancer Institute, Assiut University, Assiut, Egypt

autor

Elhamed M.F.A.

• ICU and Pain management, South Egypt Cancer Institute, Assiut University, Assiut, Egypt

autor

Mohammed K.F.

• Tropical Medicine and Gastroenterology Department, Faculty of Medicine, Assiut University, assiut, Egypt

Bibliografia

• [1] Marrelli D, De Stefano A, de Manzoni G, Morgagni P, Di LA, Roviello F. Prediction of recurrence after radical surgery for gastric cancer: a scoring system obtained from a prospective multicenter study. Ann Surg. 2005, 241: 247-55.
• [2] Eschwège P, Dumas F, Blanchet P, et al. Haematogenous dissemination of prostatic epithelial cells during radical prostatectomy. Lancet 1995, 346: 1528-30.
• [3] Jemal A, Tiwari RC, Murray T, et al. 2004. Cancer Statistics, CA Cancer J Clin 54: 8–29.
• [4] [ACS] American Cancer Society. 2002. Cancer facts and figures 2002 [online]. Accessed 4 April 2006.
• [5] Portenoy RK. Treatment of cancer pain. Lancet 2011, 377: 2236–2247.
• [6] van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG et al .Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol 2007; 18: 1437–1449.
• [7] Burton AW, Fanciullo GJ, Beasley RD et al. Chronic pain in cancer survivor: a new frontier. Pain Med 2007; 8: 189–198.
• [8] Glare PA, Pamela S, Davies PS et al. Pain in cancer survivors. J Clin Oncol 2014; 32: 1739–1747.
• [9] Brown MDR, Juan D, Ramirez JD, Paul Farquhar-Smith P. Pain in cancer survivors. Br J Pain 2014; 8: 139–153.
• [10] Breivik H, Cherny N, Collett F et al. Cancer-related pain: a panEuropean survey of prevalence, treatment, and patient attitudes. AnnOncol 2009; 20: 1420–1433.
• [11] Greco MT, Roberto A, Corli O et al. Quality of cancer pain manage-ment: an update of a systematic review of undertreatment of patientswith cancer. J Clin Oncol 2014; 32: 4149–4154.
• [12] Cleeland CS, Gonin R, Hatfield AK et al. Pain and its treatment in out-patients with metastatic cancer. N Engl J Med 1994; 330: 592–596.
• [13] Bandieri E, Sichetti D, Luppi M et al. Is pain in patients with haemato-logical malignancies under-recognised? The results from Italian ECAD-O survey. Leuk Res 2010; 34: e334–e335.
• [14] Torre LA, Bray F, Siegel RL et al. Global cancer statistics, 2012. CA Cancer J Clin 2015; 65: 87–108.
• [15] Frankish H. 15 million new cancer cases per year by 2020, says WHO. Lancet 2003; 361: 1278.
• [16] Cherny NJ. 2000. The management of cancer pain. CA Cancer J Clin 50:70–116.
• [17] Pharo GH, Zhou L. 2005. Pharmacologic Management of Cancer Pain. JAOA, 105: S21–28.
• [18] Caraceni A, Cherny N, Fainsinger R et al. Pain measurement tools and methods in clinical research in palliative care: recommendations of an expert working group of the European Association of Palliative Care. J Pain Symptom Manage 2002; 23: 239–255.
• [19] Sun V, Borneman T, Piper B et al. Barriers to pain assessment and management in cancer survivorship. J Cancer Surviv 2008; 2: 65–71.
• [20] International Association for the Study of Pain, Mechanisms of Cancer Pain. [accessed on July 20, 2011].
• [21] Macintyre PE, Schug SA, Scott DA, et al. APM: SE Working Group of the Australian and New Zealand College of Anesthetists and Faculty of Pain Medicine. Acute Pain Management. Scientific Evidence (3rd edition), ANZCA & FPM, Melbourne; 2010.
• [22] Niraj G and Rowbotham J. Persistent post-operative pain: where are we now? Br J Anaesth 107: 25-29. 2011.
• [23] Rudin A, Flisberg P, Johansson J, Walther B, Lundberg CJ. Thoracic epidural analgesia or intravenous morphine analgesia after thoracoabdominal esophagectomy: a prospective follow-up of 201 patients. J Cardiothorac Vasc Anesth. 2005; 19(3): 350–7.
• [24] Flisberg P, Tornebrandt K, Walther B, Lundberg J. Pain relief after esophagectomy: thoracic epidural analgesia is better than parenteral opioids. J Cardiothorac Vasc Anesth. 2001; 15(3): 282–7.
• [25] Kahn L, Baxter FJ, Dauphin A, et al. A comparison of thoracic and lumbar epidural techniques for post-thoracoabdominal esophagectomy analgesia. Can J Anaesth. 1999; 46(5 Pt 1): 415–22.
• [26] Luketich JD, Land SR, Sullivan EA, et al. Thoracic epidural versus intercostal nerve catheter plus patient-controlled analgesia: a randomized study. Ann Thorac Surg. 2005; 79(6): 1845–1849.
• [27] Debreceni G, Molnar Z, Szelig L, Molnar TF. Continuous epidural or intercostal analgesia following thoracotomy: a prospective randomized double-blind clinical trial. Acta Anaesthesiol Scand. 2003; 47(9): 1091–5.
• [28] Francois T, Blanloeil Y, Pillet F, et al. Effect of interpleural administration of bupivacaine or lidocaine on pain and morphine requirement after esophagectomy with thoracotomy: a randomized, double-blind and controlled study. Anesth Analg. 1995; 80(4): 718–23.
• [29] Wheatley III GH, Rosenbaum DH, Paul MC, et al. Improved pain management outcomes with continuous infusion of a local anesthetic after thoracotomy. J Thorac Cardiovasc Surg. 2005; 130(2): 464–8.
• [30] .Marret E, Bazelly B, Taylor G, et al. Paravertebral block with ropivacaine 0.5% versus systemic analgesia for pain relief after thoracotomy. Ann Thorac Surg. 2005; 79(6): 2109–13.
• [31] Casati A, Alessandrini P, Nuzzi M, et al. A prospective, randomized, blinded comparison between continuous thoracic paravertebral and epidural infusion of 0.2% ropivacaine after lung resection surgery. Eur J Anaesthesiol. 2006; 23(12): 999–1004.
• [32] Davies RG, Myles PS, Graham JM. A comparison of the analgesic efficacy and side-effects of paravertebral vs epidural blockade for thoracotomy – a systematic review and meta-analysis of randomized trials. Br J Anaesth. 2006; 96(4): 418–26.
• [33] Conlon NP, Shaw AD, Grichnik KP. Postthoracotomy paravertebral analgesia: will it replace epidural analgesia? Anesthesiol Clin. 2008; 26(2): 369–80, viii.
• [34] Daly DJ, Myles PS. Update on the role of paravertebral blocks for thoracic surgery: are they worth it? Curr Opin Anaesthesiol. 2009; 22(1): 38–43.
• [35] Yegin A, Erdogan A, Kayacan N, Karsli B. Early postoperative pain management after thoracic surgery; pre- and postoperative versus postoperative epidural analgesia: a randomised study. Eur J Cardiothorac Surg. 2003; 24(3): 420–4.
• [36] Bong CL, Samuel M, Ng JM, Ip-Yam C. Effects of preemptive epidural analgesia on post-thoracotomy pain. J Cardiothorac Vasc Anesth. 2005; 19(6): 786–93.
• [37] Katz J, Jackson M, Kavanagh BP, Sandler AN. Acute pain after thoracic surgery predicts long-term post-thoracotomy pain. Clin J Pain. 1996; 12(1): 50–5.